WallStreetZenWallStreetZen

NYSE: STVN
Stevanato Group Spa Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their STVN stock forecasts and price targets.

Forecast return on equity

Is STVN forecast to generate an efficient return?

Company
17.4%
Industry
17.61%
Market
-21.43%
STVN's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is STVN forecast to generate an efficient return on assets?

Company
10.35%
Industry
12.51%
STVN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

STVN earnings per share forecast

What is STVN's earnings per share in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$0.60+4.74%
Avg 2 year Forecast
$0.73+26.3%
Avg 3 year Forecast
$0.95+64.06%
STVN's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

STVN revenue forecast

What is STVN's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$1.4B+1.1%
Avg 2 year Forecast
$1.5B+10.91%
Avg 3 year Forecast
$1.7B+22.81%
STVN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

STVN earnings growth forecast

How is STVN forecast to perform vs Medical Instruments & Supplies companies and vs the US market?

Company
14.33%
Industry
19.33%
Market
19.28%
STVN's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
STVN's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
STVN's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

STVN revenue growth forecast

How is STVN forecast to perform vs Medical Instruments & Supplies companies and vs the US market?

Company
5.62%
Industry
7.51%
Market
11.8%
STVN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
STVN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

STVN vs Medical Stocks

TickerPricePrice TargetUp/downsideConsensus
STVN$26.93N/AN/A
ATR$134.65$181.33+34.67%Strong Buy
RGEN$119.39$163.78+37.18%Buy
TFX$125.62$142.20+13.20%Hold
BLCO$15.12$15.38+1.69%Hold
View Top Medical Stocks

Stevanato Group Spa Stock Forecast FAQ

What is STVN's earnings growth forecast for 2025-2027?

(NYSE: STVN) Stevanato Group Spa's forecast annual earnings growth rate of 14.33% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of 19.33%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.28%.

Stevanato Group Spa's earnings in 2025 is $158,303,529.On average, 3 Wall Street analysts forecast STVN's earnings for 2025 to be $182,704,902, with the lowest STVN earnings forecast at $181,705,522, and the highest STVN earnings forecast at $184,733,947. On average, 4 Wall Street analysts forecast STVN's earnings for 2026 to be $220,317,945, with the lowest STVN earnings forecast at $190,790,798, and the highest STVN earnings forecast at $236,217,178.

In 2027, STVN is forecast to generate $286,186,197 in earnings, with the lowest earnings forecast at $278,615,133 and the highest earnings forecast at $293,757,260.

If you're new to stock investing, here's how to buy Stevanato Group Spa stock.

What is STVN's revenue growth forecast for 2025-2027?

(NYSE: STVN) Stevanato Group Spa's forecast annual revenue growth rate of 5.62% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.51%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.8%.

Stevanato Group Spa's revenue in 2025 is $1,347,170,588.On average, 3 Wall Street analysts forecast STVN's revenue for 2025 to be $412,459,420,331, with the lowest STVN revenue forecast at $411,502,437,917, and the highest STVN revenue forecast at $413,207,441,394. On average, 3 Wall Street analysts forecast STVN's revenue for 2026 to be $452,493,992,220, with the lowest STVN revenue forecast at $447,489,216,470, and the highest STVN revenue forecast at $456,238,337,335.

In 2027, STVN is forecast to generate $501,048,433,174 in revenue, with the lowest revenue forecast at $500,444,262,315 and the highest revenue forecast at $501,652,604,033.

What is STVN's forecast return on assets (ROA) for 2025-2027?

(NYSE: STVN) forecast ROA is 10.35%, which is lower than the forecast US Medical Instruments & Supplies industry average of 12.51%.

What is STVN's Earnings Per Share (EPS) forecast for 2025-2027?

(NYSE: STVN) Stevanato Group Spa's current Earnings Per Share (EPS) is $0.58. On average, analysts forecast that STVN's EPS will be $0.60 for 2025, with the lowest EPS forecast at $0.60, and the highest EPS forecast at $0.61. On average, analysts forecast that STVN's EPS will be $0.73 for 2026, with the lowest EPS forecast at $0.63, and the highest EPS forecast at $0.78. In 2027, STVN's EPS is forecast to hit $0.95 (min: $0.92, max: $0.97).

What is STVN's forecast return on equity (ROE) for 2025-2027?

(NYSE: STVN) forecast ROE is 17.4%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.